News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

UC Irvine opens clinical trial of novel treatment for brain cancer

Al's Comment:

  This is one of my favorite clincial trials (it is being done all over the USA) ... however, the problem is that you need to enter the trial BEFORE your first brain tumor surgery.  Most people do not hear about this until after it is too late  We need to spread word of options such as these.  My pet peeve is that most neurosurgeons will not discuss the fact that by doing the surgery you will be forever excluded from clinical trials that require you to join before the first surgery.   Something to think about if you are about to have that first surgery.


Posted on: 10/11/2012

 

UC Irvine opens clinical trial of novel treatment for brain cancer


10/10/2012 21:25:00Vaccine made with patient’s own cells targets tumor for destruction
Orange, Calif., — UC Irvine doctors are enrolling patients with the deadly brain tumor glioblastoma multiforme in a clinical trial of a vaccine that may prevent the cancer’s return or spread after surgery.
“Our goal is to train the immune system to recognize and attack the cancer,” said Dr. Daniela Bota, neuro-oncologist and co-director of UC Irvine’s Comprehensive Brain Tumor Program. She will lead the Phase II trial at UC Irvine of DCVax, which was associated with increased survival in a previous study.

The vaccine is prepared in a lab and combines protein antigens extracted from the patient’s tumor with some of his or her white blood cells. These grow into dendritic cells that, when injected back into the patient, target the protein antigens and prompt the immune system’s T cells to identify and attack remaining cancer cells.

“Cancer cells are like crabgrass: Once they take root, they’re hard to eradicate, even after brainsurgery,” Bota said. The current treatment for patients with glioblastoma multiforme involves surgeryto remove as much of the tumor as possible, followed by radiation and chemotherapy.

“The standard of care prolongs survival, but it does not fully destroy the cancer,” Bota said. She believes the vaccine can help eliminate remaining tumor cells and further extend patients’ lives. Only 10 percent of the 12,000 to 14,000 people annually found to have glioblastoma multiforme survive five years.

Patients 18 to 70 newly diagnosed with this brain tumor (also called grade IV astrocytoma) may be eligible to enroll in the trial. For more information, call UC Irvine toll-free at 877-UCSTUDY ( 877-827-8839 ) or email ucstudy@uci.edu. Please refer to protocol UCI-08-16.

Additional information also is available at http://clinicaltrials.gov/show/NCT00045968.

Clinical trials are conducted at UC Irvine’s Chao Family Comprehensive Cancer Center, one of only 41 National Cancer Institute-designated comprehensive cancer centers in the country and the only one in Orange County.

About UC Irvine Medical Center: Orange County’s only university hospital, UC Irvine Medical Center offers acute- and general-care services at its new, 482,000-square-foot UC Irvine Douglas Hospital and is home to the county’s only Level I trauma center, American College of Surgeons-verified regional burn center and National Cancer Institute-designated comprehensive cancer center. U.S. News & World Report has included UC Irvine for 12 consecutive years on its list of America’s Best Hospitals, giving special recognition to its urology, gynecology, kidney disorders and cancer programs.

 

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740